Contact
  • Real-time
    PCR
  • CE-IVD
    marked

Anyplex™ II
HPV HR Detection

Simultaneous detection of 14 high-risk HPV genotypes in a single reaction

Anyplex™Ⅱ HPV HR Detection simultaneously detects, differentiates and quantifies 14 high-risk HPV genotypes including HPV16 and HPV18 which are implicated as major risk factors for cervical cancer. Based on Seegene’s proprietary DPO™ and TOCE™ technologies, this assay performs on multiplex real-time PCR instrument and enables accurate screening test of HPV infection in a single reaction.

Features

Result

The result represents co-infection that HPV 16 is low (+) in the HEX channel, HPV 18 is intermediate (++) in the Quasar 670 channel.

Publication

- Anyplex II HPV28 detection and Anyplex II HPV HR detection assays are highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities.

- Clinical Validation of Anyplex II HPV HR Detection Test for Cervical Cancer Screening in Korea

- Clinical validation of Anyplex™ II HPV HR Detection according to the guidelines for HPV test requirements for cervical cancer screening

- Comparison of the performance of Anyplex II HPV HR, the Cobas 4800 human papillomavirus test and Hybrid Capture 2

- Clincal validation of the Anyplex II HPV HR Detection for the Cervical Cancer Screening

We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our cookie policy.